ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects
Clinical trial NCT05668429 · COMPLETED
Trial details
- NCT number
- NCT05668429
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2023-01-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.